[Acute renal failure after gadolinium-containing contrast medium in preexisting chronic renal failure stage II].
BACKGROUND
Gadolinium-containing contrast media in low concentration as normally used in magnetic resonance imaging are considered to be safe in patients with slightly impaired renal function.


METHODS
A case of acute renal failure after administration of gadolinium 0.09 mmol/kg body weight in a patient with preexisting mild renal failure (creatinine clearance 55 ml/min) is described. The additional renal damage was partially reversible.


CONCLUSIONS
The reason for the preexisting renal failure was light-chain disease type kappa. This kind of renal damage may be especially susceptible to contrast media toxicity.
Jürgensen
Thomas
T
Medizinische Klinik, Kreiskrankenhaus Rendsburg, Rendsburg.
Brossmann
Joachim
J
Herrlinger
Jörg Dieter
JD
D058186:Acute Kidney Injury / Q000097:blood / Q000139:chemically induced*; D000368:Aged; D049448:Cholangiopancreatography, Magnetic Resonance; D003287:Contrast Media / Q000633:toxicity*; D005260:Female; D005682:Gadolinium; D042882:Gallstones / Q000175:diagnosis; D006571:Heterocyclic Compounds / Q000633:toxicity*; D006801:Humans; D007145:Immunoglobulin kappa-Chains / Q000097:blood; D007677:Kidney Function Tests; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000150:complications; D009942:Organometallic Compounds / Q000633:toxicity*; D051437:Renal Insufficiency / Q000097:blood / Q000150:complications*
D003287:Contrast Media; D006571:Heterocyclic Compounds; D007145:Immunoglobulin kappa-Chains; D009942:Organometallic Compounds; C062402:gadoteridol; D005682:Gadolinium